November 4, 2014 — A new study has added more evidence linking Abilify and impulse-control disorders, such as gambling addiction, hyper-sexuality, and obsessive shopping.
The study, published last month in JAMA Internal Medicine, reported 37 cases of behavior disorders in patients on Abilify.
A much stronger signal was seen for Mirapex and Requip, which are Parkinson’s disease treatments. They belong to the same class as Abilify, dopamine receptor agonists.
Findings of the study led researchers to warn that drug-makers may not be doing enough to warn about the risk. They are calling for a Black Box Warning on Parkinson’s drugs.
Evidence linking Abilify and gambling addiction dates back to at least 2009 and several recent studies have also linked Abilify and gambling disorders:
- In 2011, three case reports of Abilify-induced gambling addiction in schizophrenic patients were published in the British Journal of Psychiatry.
- Another study, also published in 2011, described three additional cases in patients who had no history of gambling addiction before taking Abilify. All of the patients improved after discontinuing the drug.
- Last year, French researchers published a study in Addictive Behavior describing 7 cases of gambling addiction that were possibly caused by Abilify.
Do I have an Abilify Gambling Addiction Lawsuit?
The Schmidt Firm, LLP is currently accepting Abilify induced injury cases in all 50 states. If you or somebody you know has been diagnosed with a gambling addiction or other compulsive behavior disorder, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.